MIRAE ASSET GBL INVMTS (HK)LTD GLOBAL X CHINA MEDTECH ETFMIRAE ASSET GBL INVMTS (HK)LTD GLOBAL X CHINA MEDTECH ETFMIRAE ASSET GBL INVMTS (HK)LTD GLOBAL X CHINA MEDTECH ETF

MIRAE ASSET GBL INVMTS (HK)LTD GLOBAL X CHINA MEDTECH ETF

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪14.70 M‬HKD
Fund flows (1Y)
‪−10.32 M‬HKD
Dividend yield (indicated)
Discount/Premium to NAV
1.05%
Shares outstanding
‪350.00 K‬
Expense ratio
0.68%

About MIRAE ASSET GBL INVMTS (HK)LTD GLOBAL X CHINA MEDTECH ETF


Issuer
Mirae Asset Global Investments Co., Ltd.
Brand
Global X
Inception date
Aug 3, 2023
Index tracked
Solactive China MedTech Index - CNH - Benchmark TR Net
Replication method
Synthetic
Management style
Passive
Dividend treatment
Distributes
Primary advisor
Mirae Asset Global Investments (Hong Kong) Ltd.
ISIN
HK0000945649
The investment objective of the Sub-Fund is to provide investment results that, before fees and expenses, closely correspond to the performance of the Solactive China MedTech Index (the “Index”).

Classification


Asset Class
Equity
Category
Sector
Focus
Theme
Niche
Broad technology
Strategy
Vanilla
Geography
China
Weighting scheme
Market cap
Selection criteria
Market cap

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund


As of May 27, 2025
Exposure type
StocksBonds, Cash & Other
Health Technology
Retail Trade
Health Services
Stocks98.63%
Health Technology59.07%
Retail Trade12.03%
Health Services10.55%
Technology Services9.23%
Process Industries7.75%
Bonds, Cash & Other1.37%
Cash1.37%
Stock breakdown by region
100%
Asia100.00%
North America0.00%
Latin America0.00%
Europe0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows



Frequently Asked Questions


2841 invests in stocks. The fund's major sectors are Health Technology, with 59.07% stocks, and Retail Trade, with 12.03% of the basket. The assets are mostly located in the Asia region.
2841 top holdings are JD Health International, Inc. and Shanghai United Imaging Healthcare Co., Ltd. Class A, occupying 12.03% and 9.30% of the portfolio correspondingly.
2841 assets under management is ‪14.70 M‬ HKD. It's risen 22.42% over the last month.
2841 fund flows account for ‪−10.32 M‬ HKD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, 2841 doesn't pay dividends to its holders.
2841 shares are issued by Mirae Asset Global Investments Co., Ltd. under the brand Global X. The ETF was launched on Aug 3, 2023, and its management style is Passive.
2841 expense ratio is 0.68% meaning you'd have to pay 0.68% of your investment to help manage the fund.
2841 follows the Solactive China MedTech Index - CNH - Benchmark TR Net. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
2841 invests in stocks.
2841 price has risen by 7.46% over the last month, and its yearly performance shows a 3.19% increase. See more dynamics on 2841 price chart.
NAV returns, another gauge of an ETF dynamics, have risen by 6.16% over the last month, showed a 0.48% increase in three-month performance and has increased by 2.36% in a year.
2841 trades at a premium (0.88%) meaning the ETF is trading at a higher price than the calculated NAV.